Every few years, drug development goes through a moment where a new technology promises to change everything. Artificial ...

The joint effort began with AI-assisted IND submission preparation and has since expanded to HAQ and RTQ processes.

Insilico Medicine ("Insilico"), a clinical-stage company focused on generative AI-driven drug discovery and development, ...

RNA-based drugs are emerging as the drug of the future for a wide range of diseases, but they are difficult and ...

The pharmaceutical industry invests heavily in technologies—$57.4 billion in 2022 alone—to discover new therapies to treat our greatest health challenges. Yet drug development teams are still using ...

Uniting leaders pioneering complement-targeted therapies across ophthalmology, neurodegeneration, nephrology, oncology and ...

Glucagon-like peptide agonists (GLP-1s, like Ozempic, Wegovy, and Mounjaro) have been hailed as breakthroughs. From statins to Viagra, occasionally a drug development breakthrough occurs that is ...

A major forum in Seoul will explore AI's potential to revolutionise drug development, with sessions on its impact across ...

President Donald Trump’s drug pricing policy has two China blind spots. The first is that Washington is pressing other ...

Foundation models will change the way we study the natural, applied and clinical sciences, but only under certain conditions, ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public. Researchers have applied ...